Imunon, Inc.
IMNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000749647
In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Imunon, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +4 vs. Q1 2026
- Shares held
- 318.7K
- −184.9K (−36.7%) vs. Q1 2026
- Total value
- $506.1K
- −$1.12M (−68.9%) vs. Q1 2026
- New holders
- 6
- 2 more added
- Sold out
- 2
- 4 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMNN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $506.1K |
| Q1 2026 | 19 | $1.63M |
| Q4 2025 | 20 | $1.76M |
| Q3 2025 | 17 | $879.0K |
| Q2 2025 | 26 | $1.76M |
| Q1 2025 | 19 | $359.9K |
| Q4 2024 | 22 | $403.5K |
| Q3 2024 | 22 | $1.08M |
| Q2 2024 | 18 | $442.0K |
| Q1 2024 | 18 | $539.4K |
| Q4 2023 | 22 | $285.9K |
| Q3 2023 | 18 | $402.9K |
| Q2 2023 | 17 | $515.1K |
| Q1 2023 | 19 | $513.3K |
| Q4 2022 | 22 | $572.7K |
| Q3 2022 | 22 | $818.1K |
| Q2 2022 | 25 | $1.69M |
| Q1 2022 | 24 | $2.66M |
| Q4 2021 | 42 | $4.14M |
| Q3 2021 | 40 | $8.54M |
| Q2 2021 | 43 | $11.5M |
| Q1 2021 | 47 | $16.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Imunon, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 144,767 | $257.7K | 0.01% | −203,563−58.4% | Reduced |
| Vanguard Capital Management LLC | 46,967 | $83.6K | 0.00% | −1,089−2.3% | Reduced |
| Geode Capital Management, LLC | 31,629 | $56.3K | 0.00% | −1,582−4.8% | Reduced |
| Virtu Financial LLC | 17,456 | $31.0K | 0.00% | +17,456 | New |
| Vanguard Fiduciary Trust Co | 13,269 | $23.6K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 10,342 | $18.4K | 0.00% | +10,342 | New |
| UBS Group AG | 5,203 | $9.26K | 0.00% | +4,628+804.9% | Added |
| BlackRock, Inc. | 4,464 | $7.95K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,952 | $7.04K | 0.00% | +2,086+111.8% | Added |
| Wells Fargo & Company | 3,342 | $5.95K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,574 | $2.80K | 0.00% | −1,461−48.1% | Reduced |
| SBI Securities Co., Ltd. | 1,027 | $1.83K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 194 | $345 | 0.00% | +194 | New |
| JPMorgan Chase & Co | 134 | $241 | 0.00% | +134 | New |
| Caitong International Asset Management Co., Ltd | 8 | $14 | 0.00% | +8 | New |
| Group One Trading, L.P. | 6 | $11 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 3 | $5 | 0.00% | +3 | New |
| Advisor Group Holdings, Inc. | 2 | $3 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Steigerwald, Gordon & Koch Inc. | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Riverview Capital Advisers, LLC | 34,364 | – | – | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −12,055−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −5−100.0% | Sold out |